Loading...

Cellectis S.A.

CLLS•NASDAQ
Healthcare
Biotechnology
$2.52
$0.52(26.00%)

Cellectis S.A. (CLLS) Stock Chart & Performance Analysis

Explore Cellectis S.A.’s stock chart, historical data, and performance trends for a deeper market understanding.

1-Day Change
0.82%
5-Day Change
6.03%
1-Month Change
0.82%
3-Month Change
-33.51%
6-Month Change
-38.50%
Year-to-Date (YTD) Change
-32.04%
1-Year Change
-55.91%
3-Year Change
-71.53%
5-Year Change
-88.26%
All-Time (Max) Change
-97.04%

Analyzing Cellectis S.A. (CLLS) Trends Across Multiple Time Frames

Cellectis S.A. Charts reveal critical insights by breaking down performance into different periods from short-term swings to long-term trends. Cellectis S.A. stock shows 0.82% 1-day change, indicating immediate volatility, while its 5-day change of 6.03% suggests a broader trend. Over a 1-month period, a 0.82% rise could signal a pushback, whereas a 3-month decline of -33.51% may reflect broader market sentiment. Longer timeframes help assess sustained performance. A 6-month change of -38.50% and a YTD drop of -32.04% might concern investors, but a 1-year loss of -55.91% and a 3-year drop of -71.53% could indicate resilience. The 5-year surge of -88.26% highlights weak historical growth, while the all-time return of -97.04% underscores long-term potential. Whether tracking intraday moves or multi-year trends, analyzing these metrics helps traders and investors make data-driven decisions.

Frequently Asked Questions

;